Literature DB >> 11603510

Statin myopathies: pathophysiologic and clinical perspectives.

S K Baker1, M A Tarnopolsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11603510

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN： 0147-958X            Impact factor:   0.825


× No keyword cloud information.
  15 in total

1.  Statin myopathy: incidence, risk factors, and pathophysiology.

Authors:  Kimberly A Sewright; Priscilla M Clarkson; Paul D Thompson
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

Review 2.  The effects of statin medications on aerobic exercise capacity and training adaptations.

Authors:  Zsolt Murlasits; Zsolt Radák
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

Review 3.  Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.

Authors:  J David Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

4.  Mechanisms of statin-induced myalgia assessed by physiogenomic associations.

Authors:  Gualberto Ruaño; Andreas Windemuth; Alan H B Wu; John P Kane; Mary J Malloy; Clive R Pullinger; Mohan Kocherla; Kali Bogaard; Bruce R Gordon; Theodore R Holford; Ankur Gupta; Richard L Seip; Paul D Thompson
Journal:  Atherosclerosis       Date:  2011-07-20       Impact factor: 5.162

5.  Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications.

Authors:  Jim S Wu; Catherine Buettner; Howard Smithline; Long H Ngo; Robert L Greenman
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

6.  The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

Authors:  Jun-ichi Hanai; Peirang Cao; Preeti Tanksale; Shintaro Imamura; Eriko Koshimizu; Jinghui Zhao; Shuji Kishi; Michiaki Yamashita; Paul S Phillips; Vikas P Sukhatme; Stewart H Lecker
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Alterations in zebrafish development induced by simvastatin: Comprehensive morphological and physiological study, focusing on muscle.

Authors:  Laise M Campos; Eduardo A Rios; Livia Guapyassu; Victor Midlej; Georgia C Atella; Suzana Herculano-Houzel; Marlene Benchimol; Claudia Mermelstein; Manoel L Costa
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-20

8.  Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect.

Authors:  Peirang Cao; Jun-Ichi Hanai; Preeti Tanksale; Shintaro Imamura; Vikas P Sukhatme; Stewart H Lecker
Journal:  FASEB J       Date:  2009-04-30       Impact factor: 5.191

9.  Effects of D-003 on the Lipid Profile of Patients with Type II Hypercholesterolaemia : A Phase II Clinical Study.

Authors:  Gladys Castaño; Rosa Mas; Lilia Fernández; José Illnait; Ernesto López; Rafael Gámez; Sarahi Mendoza; Julio Fernández; Meylin Mesa
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

10.  Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.

Authors:  Gladys Castaño; Rosa Más; Julio Fernández; Ernesto López; José Illnait; Lilia Fernández; Meylin Mesa
Journal:  Curr Ther Res Clin Exp       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.